Work

Abstract CT038: Combination of risvutatug rezetecan and adebrelimab in previously treated advanced nsq-NSCLC without actionable genomic alterations: Results from ARTEMIS-101, a phase 1 study

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct038

Authors: Hua Zhong, Haifeng Liu, Wei Zheng, Linlin Wang, Baogang Liu, Fangling Ning, Yongzhong Luo, Qiming Wang, Weiliang Zhu, Jianying Zhou, Qingwei Zhao, Ruoyu Wang, Xiang Li, Juan Li, Runbo Zhong, Yizhou Jin, Xiangru Mao, Jing Wang, Qingyuan Liu, Xiaoqing Zhang

Institutions: Shanghai Jiao Tong University, Shanghai Chest Hospital, Jilin Province Tumor Hospital, Sheng Jing Hospital, China Medical University, Shandong First Medical University, Harbin Medical University, Hunan Cancer Hospital, Zhengzhou University, Henan Cancer Hospital, Zhujiang Hospital, Southern Medical University, First Affiliated Hospital Zhejiang University, Zhejiang University, Dalian University, Affiliated Zhongshan Hospital of Dalian University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154687085

Cites:

Cited by:

Related to: